Overview
Congenital factor V deficiency, also known as Owren disease or parahemophilia, is a rare inherited bleeding disorder caused by a deficiency or dysfunction of coagulation factor V (also called labile factor or proaccelerin). Factor V plays a critical role in the blood clotting cascade, serving as an essential cofactor for factor Xa in the conversion of prothrombin to thrombin. Without adequate functional factor V, the body's ability to form stable blood clots is significantly impaired. The severity of bleeding symptoms generally correlates with the level of residual factor V activity. Patients with severe deficiency (factor V levels below 1%) may present in the neonatal period or early childhood with serious bleeding manifestations including intracranial hemorrhage, umbilical cord bleeding, and gastrointestinal hemorrhage. More moderate forms may present with epistaxis (nosebleeds), easy bruising, menorrhagia (heavy menstrual bleeding) in women, prolonged bleeding after surgery or dental procedures, and mucocutaneous bleeding. Joint bleeding (hemarthrosis) and muscle hematomas, while characteristic of other clotting factor deficiencies, are less common in factor V deficiency but can occur in severe cases. There is no factor V concentrate currently available for treatment. Management of bleeding episodes and surgical prophylaxis relies primarily on fresh frozen plasma (FFP), which contains factor V. Platelet transfusions may also be beneficial since platelets contain approximately 20% of the body's factor V in their alpha granules. Antifibrinolytic agents such as tranexamic acid can be used as adjunctive therapy, particularly for mucosal bleeding. Women with heavy menstrual bleeding may benefit from hormonal therapies. Patients are advised to avoid antiplatelet medications and to coordinate with a hematologist for any planned surgical or dental procedures.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventUniversity Hospital, Angers — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Congenital factor V deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital factor V deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersCHU Angers
📍 Angers
👤 Julien Rossignol, Dr
Stanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🏥 NORDBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
Travel Grants
No travel grants are currently matched to Congenital factor V deficiency.
Community
No community posts yet. Be the first to share your experience with Congenital factor V deficiency.
Start the conversation →Latest news about Congenital factor V deficiency
Disease timeline:
New trial: Evaluation of a Screening Strategy of Fabry Disease in Patient With Renal Biopsy
Phase NA trial recruiting. Detection of Fabry disease
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital factor V deficiency
What is Congenital factor V deficiency?
Congenital factor V deficiency, also known as Owren disease or parahemophilia, is a rare inherited bleeding disorder caused by a deficiency or dysfunction of coagulation factor V (also called labile factor or proaccelerin). Factor V plays a critical role in the blood clotting cascade, serving as an essential cofactor for factor Xa in the conversion of prothrombin to thrombin. Without adequate functional factor V, the body's ability to form stable blood clots is significantly impaired. The severity of bleeding symptoms generally correlates with the level of residual factor V activity. Patients
How is Congenital factor V deficiency inherited?
Congenital factor V deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Congenital factor V deficiency?
16 specialists and care centers treating Congenital factor V deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.